Teplizumab

Drug identity checked against registry records

Also recorded as MGA031

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes MellitusNCT00385697MacroGenicsPhase 2, Phase 3Completed2010-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.